About the partnership
The European and Developing Countries Clinical Trials Partnership (EDCTP) exists to accelerate the clinical development of new or improved medicinal products for the identification, treatment and prevention of poverty-related and neglected infectious diseases, including (re-)emerging diseases.
In addition, the EDCTP funds activities for research capacity building in Africa, supporting researchers’ careers and strengthening national health research systems.
EDCTP in Horizon Europe
The Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU) builds on the first and second EDCTP programmes. This new joint undertaking is a partnership between the EU and the EDCTP Association, whose members are several European and African countries. The GH EDCTP3 is fully embedded in the AU-EU High-Level Policy Dialogue on Science, Technology and Innovation.
This partnership will deliver new solutions for reducing the burden of infectious diseases in sub-Saharan Africa, and strengthen research capacities to prepare and respond to re-emerging infectious diseases in this region and across the world.
By 2030, the GH EDCTP3 aims to develop and deploy at least two new technologies tackling infectious diseases, and support at least 100 research institutes in 30 countries to develop additional health technologies against infectious diseases.
Why international cooperation in health research is important
International cooperation is a fundamental and inherent component of health research. In recent decades, the African Union Commission and the European Commission have strengthened their collaboration on global health and multilateral research. The current health disparities and the asymmetries in global health and health research reveal the importance of a strong cooperation between Africa and Europe to address these issues.